Researchers showed that in C. elegans, the protein MBD-2 regulates genes through repressive histone marks rather than DNA ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

Recently, the research team led by Professor Jun Pang from the Department of Urology at The Seventh Affiliated Hospital of Sun Yat-sen University ...

Researchers at the School of Biological Sciences of The University of Hong Kong (HKU) have uncovered how eukaryotic cells can ...

Explore the complexities of tauopathies and how new research could change their diagnosis and treatment approaches.

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Researchers identified UBL3 as a regulator that loads PD-L1 into tumor extracellular vesicles, weakening immunotherapy. They ...

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

The partnership is supported by the Michael J. Fox Foundation, which seeks to better understand aSyn protein's role in Parkinson's disease.

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease.